Cortagen vs Epitalon
How Cortagen and Epitalon compare — what each is, how strong the human evidence is for each, doses reported in research, the key risks, and 2026 US legal status. No universal winner.
Cortagen and Epitalon come up together when people are weighing similar options. Here's the honest side-by-side: what each is, how strong the human evidence is for each, the doses reported in research, the risks, and where each stands with the FDA as of 2026. There's no universal winner — scroll to the by-goal picks for which one fits which goal.
Cortagen vs Epitalon, point by point
Every dimension side by side — the honest differences, not a scoreboard.
| Dimension | Cortagen | Epitalon |
|---|---|---|
| What it is | Synthetic tetrapeptide and proposed brain bioregulator peptide | Synthetic pineal tetrapeptide (a 4-amino-acid peptide, Ala-Glu-Asp-Gly, modeled on the pineal-gland extract epithalamin) |
| Class / category | Longevity / mitochondrial | Longevity / mitochondrial |
| Evidence tier | Animal-only · Unclear · none in humans | Animal-only · Unclear · none in humans |
| Studied / approved for | Peripheral nerve regeneration; Age-related chromatin changes; Neuroprotection | Anti-aging / lifespan extension; Telomere maintenance; Sleep & circadian regulation |
| US regulatory status (2026) | research use only (as of Jul 2026) | research use only (as of Jul 2026) |
| Doses reported in research | No established study doses | No established study doses |
| Registered trials (ClinicalTrials.gov) | No data | 0 |
| Banned in sport (WADA) | Unknown | Yes — on the WADA prohibited list |
| Key risks | No controlled trial has established an administered human dose, adverse-event rate, contraindications, or long-term safety for Cortagen. Cell and animal experiments cannot answer those questions, and research-market products add separate uncertainty about identity, purity, and sterility. | Epitalon's honest safety answer is "we don't really know in humans." No human safety trial of the synthetic peptide has been published, and long-term human data does not exist. Animal studies reported few obvious toxic effects at the small doses used, which is reassuring but not the same as human safety. The bigger real-world risk is the product itself — research-chemical vials vary in purity and sterility. |
- Evidence tier: A tier reflects how human the evidence is, not a promise the compound works.
Cortagen vs Epitalon: the two molecules
The 2D chemical structures, straight from PubChem — a quick way to see how similar (or not) the two actually are.
Which one fits which goal?
There's no universal winner here — the honest answer depends on what you're after. These picks are framed by goal, and each says why.
Which one fits your goal
These two overlap enough that the honest call comes down to your specific goal and how much human evidence you want before trying something. Compare the differences in the table above — there's no universal winner here.
References
- 1.PubChem — H-Ala-Glu-Asp-Pro-OH, CID 18439621
- 2.Turchaninova et al., 2000 — Cortagen and rat sciatic-nerve regeneration (PMID 11276314)
- 3.Anisimov et al., 2004 — Cortagen and gene expression in mouse heart (PMID 15159690)
- 4.Khavinson et al., 2004 — Short peptides and cultured human lymphocyte chromatin (PMID 15085253)
- 5.ClinicalTrials.gov — Cortagen intervention search
- 6.Drugs@FDA — FDA-approved drug database